SpyGlass Pharma Q4 EPS $(5.72) Down From $(4.58) YoY

SpyGlass Pharma (NASDAQ:SGP) reported quarterly losses of $(5.72) per share. This is a 24.89 percent decrease over losses of $(4.58) per share from the same period last year.